A panel of expert cardiologists share their concluding thoughts on management of polyvascular disease in clinical practice.
Experts in dermatology share practice pearls to advanced practice providers and community dermatologists for the management of plaque psoriasis.
Raj J. Chovatiya, MD, PhD; Alexandra K. Golant, MD; Eric Simpson, MD, MCR; and Linda Stein Gold, MD, share clinical pearls and discuss the future treatment landscape for atopic dermatitis.
Dr. Woolery-Lloyd shares her advice for vitiligo providers and tips for helpful communication with patients.
Experts in gastroenterology share take-home messages for the management of ulcerative colitis.
An expert panel shares insight on the future treatment landscape for treatment-resistant depression.
A lipidologist from Connecticut describes his experience during the COVID-19 pandemic and explains why he sees getting the vaccine as his "biggest contribution" to healthcare during the pandemic.
Shawn Kwatra, MD, and Sarina B. Elmariah, MD, PhD, share final pearls of wisdom for other physicians taking care of patients with prurigo nodularis (PN).
Drs Erin Michos, Pam Taub, Robert Busch, Alison Bailey, and Jorge Plutzky offer key takeaways in the management of hypercholesterolemia and ASCVD.
From new ACG GERD guidelines to the efficacy of colonoscopies, our latest issue addresses topics changing practice and stirring conversation.
As an industry and a society, we must take gout more seriously. That effort begins with the physicians who diagnose and treat it.
Sophie M. Lanzkron, MD, MHS; Jeffrey D. Lebensburger; and John J. Strouse, MD, PhD, share key takeaways and closing thoughts for the management of sickle cell disease.
Diana Isaacs, PharmD, BCPS, BC-ADM, CDCES, and Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCES, interview Scott Kahan, MD, MPH who serves on the committee that creates the ADA Standards of Care in Diabetes, to discuss the latest updates in weight management guidelines.
More than two-thirds of smokers want to quit, but lack proper resources. A prescribing professional could help make up that difference.
Compared with other bDMARDs, patients with rheumatoid arthritis treated with tofacitinib had a 4-fold reduced incidence of interstitial lung disease.
A narrative has depicted a pandemic situation that is completely negative. There is another way to tell the story of the past nine months.
Satralizumab represents only the second targeted treatment for NMOSD and the first cleared for at-home administration.
A panel of eye care specialists share clinical advice and future directions for the treatment of wet AMD.
A panel of eye care specialists share clinical advice and future directions for the treatment of wet AMD.
Closing out their discussion on Clostridioides difficile infection, panelists share closing thoughts on novel pipeline therapies.
A panel of expert cardiologists share their concluding thoughts on management of polyvascular disease in clinical practice.
Jayme Heim, MSN, FNP-BC, and Matthew T. Reynolds, PA-C, shares clinical pearls for clinicians managing patients with plaque psoriasis.
Dr. Woolery-Lloyd shares her advice for vitiligo providers and tips for helpful communication with patients.
Expert cardiologists share strategies for educating patients on the treatment and management of hypertrophic cardiomyopathy.